Results were similar in the other two adverse renal outcomes, although this interaction was of borderline significance for new stage 3b–5 chronic kidney disease (P=0.06).
1
0.0600
0.0600
Results were similar in the other two adverse renal outcomes, although this interaction was of borderline significance for new stage 3b–5 chronic kidney disease (P=0.06).